Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
about
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyPeripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune systemCellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patientsHepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cellsHepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapyInterferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patientsInterleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virusMonocyte activation in HIV/HCV coinfection correlates with cognitive impairment.Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infectionsPathogen-pathogen interaction: a syndemic model of complex biosocial processes in diseaseVariation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C.Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C VirusElevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivoHost gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesisDistinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells.Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania.Substance abuse, HIV-1 and hepatitisHigh-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenInterferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and RibavirinHepatitis C Virus and HIV Type 1 Co-Infection.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Comparative efficacy, pharmacokinetic, pharmacodynamic activity, and interferon stimulated gene expression of different interferon formulations in HIV/HCV genotype-1 infected patients.HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV.Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.Immunological nonresponse to antiretroviral drugs in HIV infectionSignature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection
P2860
Q27015778-96DC9552-42AA-47C9-8110-D08890935BA4Q28396147-88C78737-FC4C-4F51-92DE-58DF4402E4E6Q33584149-E2B4DA4A-6FFE-41D4-9B10-7B66F704B7A2Q33664480-324424F4-83D9-468A-BE08-5B587D58D042Q33750016-CD7E57F1-8B40-4221-8358-54CE0AD32653Q33924165-077F999C-227D-4B0A-9977-F40CAF60AE9FQ33968365-DDDE6994-5FF3-48B6-BE08-F0CD35759206Q33988140-651181BA-77D5-414F-9645-C17231A56C2CQ34242185-253E168E-CED7-49A4-9595-1C7E2981BEE4Q34329530-81B20DA8-54F6-43AB-9F8B-25EB3A142408Q34439925-401E26EE-A289-4B7E-ACAA-666DF733839BQ34824481-7EC679DD-48E6-42B9-AFE6-1C163FF2AE80Q35018340-F49A70BA-114F-4464-95D6-680701634B90Q35033949-25BD2F84-B19F-4AB6-BD31-0456D93B5EBFQ35158581-760BB4EA-5F27-4C6A-A70C-996F114F9D9EQ35535783-45190095-E1C0-4187-9ED6-1A5638919F24Q35684549-38D0A156-92EE-4C2F-A3B9-6F48F155C6D9Q35883429-EF1F88DF-F89A-42BD-ABF3-E62C16DBD0C8Q35992420-8DF31AB6-728A-4495-900D-D9DFF0D84880Q36019847-2C5CA348-6AE1-4EBC-BD93-DF0FBE638801Q36439091-BE971B94-BE1E-4D82-A31A-27E8218A1789Q36783269-554D7A3F-F79F-4179-817B-88E6EBA2ECFCQ37003023-8DE07370-5F71-4787-BB1C-CE7F43F3418AQ37012660-CC2FA1B6-4994-4F4A-890D-B49779A2E8ECQ37062210-F2662BAB-E530-416B-96B9-4C167536CE63Q37481988-E59375F1-1EF7-4932-AE61-8EAF33EB208FQ38793776-3E28295A-A9D6-42AC-8AA3-B7F48CFD6726Q39325002-5740E0F5-65A1-4171-9735-69BB33DE3890Q40238137-744F6F81-F991-4DF6-85D6-3722D6261C8BQ42991216-5B749DB5-2CF4-420B-AA12-D6573ABC4E60Q47171530-5E348025-D9DD-4E6D-BBC0-744F0659E715Q58388931-C1378BAB-12AF-461C-A59D-FF75486BB511Q58715600-989C4311-9C23-4206-AE3E-3E325721048B
P2860
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@en
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@nl
type
label
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@en
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@nl
prefLabel
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@en
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Human immunodeficiency virus a ...... peripheral mononuclear cells.
@en
P2093
Gregg Roby
Karoll J Cortez
Kristin N Reitano
Marc Ghany
Marybeth Daucher
Michael Y Yan
Xiaozhen Zhang
P2860
P356
10.1002/HEP.23055
P407
P577
2009-07-01T00:00:00Z